sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Asia Pacific Plasma Fractionation Market...

2028年までのアジア太平洋地域の血漿分画市場予測 - 製品別（免疫グロブリン、アルブミン、凝固因子濃縮物、プロテアーゼ阻害剤、その他の血漿製品）、用途別（神経学、免疫学、血液学、救命救急、呼吸器学、その他のアプリケーション）、およびエンドユーザー（病院および診療所、臨床研究研究所、学術機関）

TIPRE00026269 | Pages: 134 | Medical Device | Dec 2021 | Type: Regional | Status: Published

市場紹介

APAC は血漿分画市場で最も急速に成長しており、中国はインド、日本、韓国、オーストラリア、およびその他のアジア太平洋地域がこの地域の市場に大きく貢献しています。アジア太平洋地域は、中国やインドの国際企業の関心の高まり、中国などの政府支援、医療インフラの進歩により、2021年の世界の血漿分画市場で大きなシェアを占めた。したがって、この地域は、血漿分画市場のプレーヤーが予測期間中に成長する大きな可能性を秘めています。

サプライチェーンの混乱と、新型コロナウイルス治療のための効率的な治療法に対する多大な需要-19により、APAC地域のヘルスケア研究業界は重大な状況に陥っています。このパンデミックの蔓延を制御するために予防措置が講じられています。新型コロナウイルス感染症（COVID-19）のパンデミックは、アジア太平洋地域の経済に広範囲に影響を与えています。インド、中国、日本、韓国などの国々はパンデミックによって悪影響を受けました。社会経済は深刻な影響を受け、マイナスのインフレ、GDP、地域の失業率の上昇が見られました。中国、日本、シンガポール、韓国などの国々では、臨床試験への関心が高まっています。欧米諸国のコスト高も、医療事務のアジア太平洋地域へのアウトソーシングの流れに寄与している。アジア市場への売上を拡大するために、製薬会社は医薬品、機器、体外診断薬に対する新たな規制環境の変化を認識し始めています。アジアでは、GMP基準、薬価管理、医療機器規制制度の変更など、新規または改良された規制が頻繁に導入されています。現在の基準の取得または改善の一環として、第三者の指導とアドバイスが必要です。 APAC の関連市場をサポートする上で、サードパーティのアウトソーシング サービス プロバイダーがますます重要な役割を果たしています。ただし、制御手順、人々の意識、ワクチン接種の利用可能性、関連市場における企業に対する政府の支援政策により、パンデミックの初期段階に比べて市場は安定しています。                       

市場の概要とダイナミクス

APAC の血漿分画市場は、2021 年の 58 億 5,465 万米ドルから 2028 年までに 94 億 3,353 万米ドルに成長すると予想されています。 2021 年から 2028 年にかけて 7.1% の CAGR で成長すると推定されています。残りの APAC には、シンガポール、マレーシア、台湾、ベトナムなどの東南アジア諸国が含まれます。いくつかの国では医療機関や研究機関が大幅に成長しており、それが血漿分画市場の成長につながっています。また、糖尿病関連障害の症例数の増加も市場の発展をさらに推進しています。たとえば、2020年にMDPIジャーナル・オブ・ファーマシューティクスに掲載された報告書によると、DFUの有病率は5.5%と推定されています。マレーシアはアジアで最も糖尿病患者数が多い国としてランクされており、患者数は約360万人となっている。 2025 年までに、約 700 万人の成人が糖尿病を患い、DFU を発症する可能性があると予想されています。このような要因により、血漿分画市場の需要が増加します。       

主要市場セグメント

< APACの血漿分画市場は、製品、アプリケーション、エンドユーザー、国に分割されています。 APACの血漿分画市場は、製品に基づいて、免疫グロブリン、アルブミン、濃縮凝固因子、プロテアーゼ阻害剤などに分類されています。免疫グロブリンセグメントは、2021年に市場で最大のシェアを握ると見込まれています。APACの血漿分画市場は、アプリケーションに基づいて、神経学、免疫学、血液学、救急医療、呼吸器学などに分類されています。 2021 年には、神経科分野が市場で最大のシェアを握ると予想されます。 APACの血漿分画市場は、エンドユーザーに基づいて、病院や診療所、臨床研究研究所、学術機関に分割されています。 2021 年には、病院および診療所部門が市場で最大のシェアを握ると予想されます。国に基づいて、APACの血漿分画市場はオーストラリア、中国、インド、日本、韓国、およびその他のAPACに分割されています。 2021 年に日本が最大の市場シェアを保持しました。

リストされている主な情報源と企業

APAC の血漿分画市場に関するこのレポートを作成するために参照したいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどです。レポートに記載されている主要企業は、Bharat Serums and Vaccines Limited (BSV) です。株式会社バイオプロダクツ研究所; CSL限定。グリフォルス、SA;ケドリオン SpA; Octapharma AG; PlasmaGen BioSciences Pvt.株式会社; とSKプラズマ。           

購入理由レポート

  • アジア太平洋地域の血漿分画市場の状況を理解し、最も成長する可能性が高い市場セグメントを特定する。高い収益を保証します。
  • APAC 血漿分画市場の刻々と変化する競争環境を理解し、競争に先んじてください。
  • < span>最も売上が見込まれる市場セグメントを特定することで、APAC の血漿分画市場での M&A やパートナーシップ取引を効率的に計画します。
  • 知覚的かつ包括的な知識に基づいたビジネス上の意思決定を支援します。 APAC 血漿分画市場のさまざまなセグメントの市場パフォーマンスの分析。
  • 2021 年から 2028 年までの APAC 地域のさまざまなセグメントごとの市場収益予測を取得します。 >

アジア太平洋血漿分画市場セグメンテーション

アジア太平洋地域の血漿分画市場 - 製品別

  • 免疫グロブリン
    • 静脈内免疫グロブリン (IVIG)
    • 皮下免疫グロブリン (SCIG)
  • アルブミン
  • 凝固因子濃縮物
  • プロテアーゼ阻害剤
  • その他

アジア太平洋血漿分画市場 - By アプリケーション

  • 神経学
  • 免疫学
  • 血液学
  • 救命救急学
  • 呼吸器学
  • その他

APAC血漿分画市場 - エンドユーザー別

  • 病院と診療所
  • 臨床研究所
  • 学術機関

APAC 血漿分画市場 - 国別

  • オーストラリア
  • 中国
  • インド
  • 日本
  • 韓国
  • アジア太平洋地域のその他の地域

アジア太平洋地域の血漿分画市場 - 会社概要

  • Bharat Serums and tobaccos Limited ( BSV)
  • バイオプロダクツ研究所株式会社
  • CSL Limited
  • SA グリフォルス
  • Kedrion SpA
  • Octapharma AG
  • PlasmaGen BioSciences Pvt.株式会社
  • SK プラズマ

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Plasma Fractionation Market – By Product

1.3.2        APAC Plasma Fractionation Market – By Application

1.3.3        APAC Plasma Fractionation Market – By End User

1.3.4        APAC Plasma Fractionation Market – By Country

2.           APAC Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy is Becoming More Widely Used

5.1.2        Players' Active Involvement in Market Developments

5.2         Market Restraints

5.2.1        Options for Non-Plasma Substitutes

5.3         Market Opportunities

5.3.1        Growth Potential in Developing Countries

5.4         Future Trends

5.4.1        Novel Diseases Getting Treated with Use of Plasma Therapy

5.5         Impact Analysis

6.           Plasma Fractionation Market – APAC Analysis

6.1         APAC Plasma Fractionation Market Revenue Forecast and Analysis

7.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         APAC Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           APAC Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        APAC Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

10.1.1.1       Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Overview

10.1.1.1.2       Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.3       Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.1.4       Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.5       Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.2.1       Overview

10.1.1.2.2       China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.2.3       China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.2.4       China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.5       China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       India Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.3.1       Overview

10.1.1.3.2       India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.3.3       India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.3.4       India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.5       India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.4.1       Overview

10.1.1.4.2       South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.4.3       South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.4.4       South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.5       South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.5       Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.5.1       Overview

10.1.1.5.2       Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

10.1.1.5.3       Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3.1    Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.5.4       Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.5       Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.6       Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3.1    Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

10.1.1.6.4       Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4.1    Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on APAC Plasma Fractionation Market

11.1      APAC: Impact Assessment of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Octapharma AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Kedrion S.p.A

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      CSL Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Grifols, S.A.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bio Products Laboratory Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bharat Serums and Vaccines Limited (BSV)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      SK Plasma

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      PlasmaGen BioSciences Pvt. Ltd.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Japan: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 2.             Japan: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 3.             Japan: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Japan: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             China: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 7.             China: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             China: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             India: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 11.          India: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Korea: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Korea: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 15.          South Korea: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          South Korea: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 18.          Australia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 19.          Australia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          Australia: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of APAC: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million))

Table 23.          Rest of APAC: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic developments done by Companies

Table 27.          Glossary of Terms, APAC Plasma Fractionation Market

 


LIST OF FIGURES

Figure 1.           APAC Plasma Fractionation Market Segmentation

Figure 2.           APAC Plasma Fractionation Market Segmentation, By Country

Figure 3.           APAC Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in APAC Plasma Fractionation Market

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to APAC Plasma Fractionation Market

Figure 8.           APAC Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           APAC Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        APAC Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        APAC Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        APAC Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        APAC Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        APAC Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        APAC Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        APAC Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        APAC Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        APAC Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        APAC Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        APAC Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        APAC Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        APAC Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        APAC Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        APAC Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        APAC Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        APAC Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        APAC Plasma Fractionation Market Overview, by Country (2018)

Figure 29.        APAC: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

Figure 30.        Japan: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 32.        India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 33.        South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 34.        Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 35.        Rest of APAC: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        Impact of COVID-19 Pandemic in APAC Country Markets

Figure 37.        Growth Strategies Followed by Major Market Players (%)

  1. Bharat Serums and Vaccines Limited (BSV)
  2. Bio Products Laboratory Ltd.
  3. CSL Limited
  4. Grifols, S.A.
  5. Kedrion S.p.A
  6. Octapharma AG
  7. PlasmaGen BioSciences Pvt. Ltd.
  8. SK Plasma
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC plasma fractionation market   
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription